Skip to content

Biomechanical intervention effect and development of in-toe gait orthopedic shoes for children

Biomechanical intervention effect and development of in-toe gait orthopedic shoes for children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600129709
Enrollment
Unknown
Registered
2026-08-07
Start date
2026-08-07
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intoeing gait

Interventions

Control group (standard shoe group):Wear standard sneakers
Pilot experimental group:Wear prototype shoes equipped with different orthotic modules
Xperimental group (custom in-toe shoe group):Wear custom-made in-toe correction shoes

Sponsors

Beijing Bo'ai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Basic Information Requirements (1) Age: >= 5 years and <= 18 years; (2) No gender restriction. 2. Disease Diagnosis and Laboratory Indicators (1) Inclusion Diagnostic Criteria: 1) Subjects must meet the diagnostic criteria for developmental intoeing gait; 2) Able to walk independently and naturally, and cooperate to complete all experimental tests and follow-up visits; 3) Exclusion of confounding comorbidities: Subjects shall have no other gait abnormalities, no past or current history of neurological, muscular or skeletal disorders; no lower extremity injuries within the past six months, and no concurrent medication that may affect gait. (2) Key Indicator: Foot Progression Angle (FPA) < 0°.

Exclusion criteria

Exclusion criteria: 1. Intoeing gait caused by skeletal, neurological or muscular disorders (e.g., cerebral palsy, rickets, congenital hip dysplasia, etc.); 2. Subjects with a history of surgery or fracture; 3. Presence of severe cardiopulmonary dysfunction, cognitive impairment or psychiatric disorders; 4. Currently participating in other clinical studies; 5. Allergy to materials of the gait-correcting footwear; 6. Failure to guarantee completion of the full follow-up period.

Design outcomes

Primary

MeasureTime frame
Foot Progression Angle;

Secondary

MeasureTime frame
Tibial Malleolar Angle;Wearing compliance;Lower Limb Biomechanical Parameters(Joint Angles,Center of Pressure Deviation,Ground Reaction Force,etc.);Maximum Hip Internal Rotation Angle;Spatio-temporal gait parameters ( Step Width, Gait Speed, etc.);Visual Analogue Scale;Incidence rate of adverse events;

Countries

China

Contacts

Public ContactGuo Manting

Beijing Bo'ai Hospital

156620147@qq.com+86 10 67588120

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026